BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12503217)

  • 1. Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy.
    Mizejewski GJ
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):709-35. PubMed ID: 12503217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research advances on alpha-fetoprotein physiological function and clinical potential].
    Yin ZF; Wang CH
    Ai Zheng; 2003 Jan; 22(1):108-11. PubMed ID: 12561448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha-fetoprotein-derived growth inhibitory peptide 8-mer fragment: review of a novel anticancer agent.
    Mizejewski GJ
    Cancer Biother Radiopharm; 2007 Feb; 22(1):73-98. PubMed ID: 17627416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human alpha fetoprotein synergistically potentiates the anti-cancer effects of 1'-S-1'-acetoxychavicol acetate when used as a complex against human tumours harbouring AFP-receptors.
    Arshad NM; In LL; Soh TL; Azmi MN; Ibrahim H; Awang K; Dudich E; Tatulov E; Nagoor NH
    Oncotarget; 2015 Jun; 6(18):16151-67. PubMed ID: 26158863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-fetoprotein signal sequences: a proposed mechanism for subcellular localization and organelle targeting.
    Mizejewski GJ
    J Theor Biol; 1995 Sep; 176(1):103-13. PubMed ID: 7475095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The receptor binding fragment of alpha-fetoprotein is a promising new vector for the selective delivery of antineoplastic agents.
    Posypanova GA; Makarov VA; Savvateeva MV; Bereznikova AV; Severin ES
    J Drug Target; 2013 May; 21(5):458-65. PubMed ID: 23600748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-fetoprotein-binding toxins and teratogens against cancer.
    Pak VN
    Ther Deliv; 2019 Jan; 10(1):1-3. PubMed ID: 30730821
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha-fetoprotein receptors in a human breast cancer cell line.
    Villacampa MJ; Moro R; Naval J; Failly-Crepin C; Lampreave F; Uriel J
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1322-7. PubMed ID: 6206854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the putative cell-surface receptors for alpha-fetoprotein: identification of a candidate receptor protein family.
    Mizejewski GJ
    Tumour Biol; 2011 Apr; 32(2):241-58. PubMed ID: 21120646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.
    Cavin LG; Venkatraman M; Factor VM; Kaur S; Schroeder I; Mercurio F; Beg AA; Thorgeirsson SS; Arsura M
    Cancer Res; 2004 Oct; 64(19):7030-8. PubMed ID: 15466196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent data on alphafetoprotein.
    Masseyeff M; Aussel C; Soubiran P
    Rev Fr Transfus Immunohematol; 1984 Dec; 27(6):767-83. PubMed ID: 6084286
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding characterization of the targeting drug AIMPILA to AFP receptors in human tumor xenografts.
    Tcherkassova J; Tsurkan S; Smirnova G; Borisova J; Moro R; Treshalina H
    Tumour Biol; 2017 Oct; 39(10):1010428317734815. PubMed ID: 28990489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of functional activities of alpha-fetoprotein derived growth inhibitory peptides: review and prospects.
    Mizejewskia GJ; Butterstein G
    Curr Protein Pept Sci; 2006 Feb; 7(1):73-100. PubMed ID: 16472170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.
    Pak VN
    Ther Deliv; 2018 Jan; 9(1):37-46. PubMed ID: 29216804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.
    Mizejewski G; Smith G; Butterstein G
    Cell Biol Int; 2004; 28(12):913-33. PubMed ID: 15566961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physiological role of alpha-fetoprotein in cell growth and differentiation.
    Uriel J
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):12-7. PubMed ID: 2480409
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis.
    Muehlemann M; Miller KD; Dauphinee M; Mizejewski GJ
    Cancer Metastasis Rev; 2005 Sep; 24(3):441-67. PubMed ID: 16258731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
    Tsukada Y; Bischof WK; Hibi N; Hirai H; Hurwitz E; Sela M
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):621-5. PubMed ID: 6176999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha fetoprotein on escape of Bel 7402 cells from attack of lymphocytes.
    Li M; Liu X; Zhou S; Li P; Li G
    BMC Cancer; 2005 Aug; 5():96. PubMed ID: 16080799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha-fetoprotein immunotherapy as a stage of combined treatment of cancer patients].
    Chereshnev VA; Rodionov SIu; Vasil'ev NV; Orlov OA; Cherkasov VA
    Vopr Onkol; 2005; 51(1):86-92. PubMed ID: 15909814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.